Showing results (6651-6660 of 45,234) with videos related to

Sort By:
Pageof 4,524
Cancer Research|December 29, 1998
Cytogenetic and fluorescence in situ hybridization characterization of chromosome 1 rearrangements in head and neck carcinomas delineate a target region for deletions within 1p11-1p13Y Jin, C Jin, J Wennerberg, et al.
Cancer Research|December 16, 1998
Absence of topoisomerase IIbeta in an amsacrine-resistant human leukemia cell line with mutant topoisomerase IIalphaC E Herzog, K A Holmes, L M Tuschong, et al.
Cancer Research|December 16, 1998
Realization of the therapeutic potential of CTLA-4 blockade in low-dose chemotherapy-treated tumor-bearing miceM B Mokyr, T Kalinichenko, L Gorelik, et al.
Cancer Research|December 16, 1998
Attenuation of telomerase activity by a hammerhead ribozyme targeting the template region of telomerase RNA in endometrial carcinoma cellsY Yokoyama, Y Takahashi, A Shinohara, et al.
Cancer Research|December 16, 1998
Expression, characterization, and detection of human uridine phosphorylase and identification of variant uridine phosphorolytic activity in selected human tumorsM Liu, D Cao, R Russell, et al.
Cancer Research|December 16, 1998
Expression of AP-2 transcription factors in human breast cancer correlates with the regulation of multiple growth factor signalling pathwaysB C Turner, J Zhang, A A Gumbs, et al.
Cancer Research|December 16, 1998
Association of the decreased expression of alpha3beta1 integrin with the altered cell: environmental interactions and enhanced soft agar cloning ability of c-myc-overexpressing small cell lung cancer cellsL F Barr, S E Campbell, B S Bochner, et al.
Cancer Research|December 16, 1998
Retinoic acid and interferon alpha act synergistically as antiangiogenic and antitumor agents against human head and neck squamous cell carcinomaM W Lingen, P J Polverini, N P Bouck
Cancer Research|December 16, 1998
MUC1 is a novel marker for the type II pneumocyte lineage during lung carcinogenesisJ A Jarrard, R I Linnoila, H Lee, et al.
Cancer Research|December 20, 2007
Adenovirus-based strategies overcome temozolomide resistance by silencing the O6-methylguanine-DNA methyltransferase promoterMarta M Alonso, Candelaria Gomez-Manzano, B Nebiyou Bekele, et al.
Pageof 4,524